Spots Global Cancer Trial Database for Immune Response in Lung Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Immune Response in Lung Cancer
Official Title: Immune Response in Lung Cancer
Study ID: NCT01955343
Conditions
Interventions
Study Description
Brief Summary: This study is designed to evaluate the importance of the immune cells localization (distribution) between malignant tumor islets and surrounding stroma and to investigate the associations between these immune cells as well as cytokines and clinicopathological and prognostic factors of non-small cell lung cancer (NSCLC) patients.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Lithuanian University of Health Sciences, Kaunas, , Lithuania
Contact Details
Name: Marius Zemaitis, Assoc.Prof.
Affiliation: Lithuanian University of Health Sciences
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
